Atorvastatin as GVHD Prophylaxis for Allogeneic Hematopoietic Cell Transplantation
This study is currently recruiting participants.
Verified January 2013 by West Virginia University
Sponsor:
Mehdi Hamadani
Information provided by (Responsible Party):
Mehdi Hamadani, West Virginia University
ClinicalTrials.gov Identifier:
NCT01665677
First received: August 13, 2012
Last updated: January 10, 2013
Last verified: January 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | December 2015 |
| Estimated Primary Completion Date: | December 2015 (Final data collection date for primary outcome measure) |